PUBLISHER: TechNavio | PRODUCT CODE: 2109347
PUBLISHER: TechNavio | PRODUCT CODE: 2109347
Global Autoimmune Disease Diagnostics Market 2026-2030
The global autoimmune disease diagnostics market is forecasted to grow by USD 3768.7 mn during 2025-2030, accelerating at a CAGR of 10.1% during the forecast period. The report on the global autoimmune disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of autoimmune disorders, technological advancements in multiplex assays and laboratory automation, heightened patient awareness and favorable healthcare initiatives.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 9.5% |
| CAGR | 10.1% |
| Incremental Value | $3768.7 mn |
Technavio's global autoimmune disease diagnostics market is segmented as below:
By Type
- Localized diagnostics
- Systemic diagnostics
By Product
- Assay kits
- Analyzer
By End-User
- Clinical laboratories
- Hospitals
- Diagnostic centers
- Research laboratories
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the adoption of multiplex autoantibody assays and high-throughput automation as one of the prime reasons driving the global autoimmune disease diagnostics market growth during the next few years. Also, integration of ai and advanced data analytics and expansion of poc testing and decentralized diagnostics will lead to sizable demand in the market.
The report on the global autoimmune disease diagnostics market covers the following areas:
- Global autoimmune disease diagnostics market sizing
- Global autoimmune disease diagnostics market forecast
- Global autoimmune disease diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global autoimmune disease diagnostics market vendors that include Autoimmune Technologies LLC, Beckman Coulter Inc., Bio Rad Laboratories Inc., BioMerieux SA, DiaSorin SpA, Exagen Inc., F. Hoffmann La Roche Ltd., Gold Standard Diagnostics Corp., Grifols SA, Hemagen Diagnostics Inc., HUMAN Diagnostics Worldwide, Immco Diagnostics Inc., Laboratory Holdings Inc., Quest Diagnostics Inc., R Biopharm AG, Revvity Inc., Siemens AG, Svar Life Science AB, Thermo Fisher Scientific Inc., Werfenlife SA. Also, the global autoimmune disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Autoimmune Disease Diagnostics Market 2020 - 2024
- Historic Market Size - Data Table on Global Autoimmune Disease Diagnostics Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global autoimmune disease diagnostics market
- 6.2 Impact of geopolitical conflicts on global autoimmune disease diagnostics market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Localized diagnostics - Market size and forecast 2025-2030
- 8.4 Systemic diagnostics - Market size and forecast 2025-2030
- 8.5 Market opportunity by Type
- Market opportunity by Type ($ million)
9 Market Segmentation by Product
- 9.1 Market segments
- 9.2 Comparison by Product
- 9.3 Assay kits - Market size and forecast 2025-2030
- 9.4 Analyzer - Market size and forecast 2025-2030
- 9.5 Market opportunity by Product
- Market opportunity by Product ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Clinical laboratories - Market size and forecast 2025-2030
- 10.4 Hospitals - Market size and forecast 2025-2030
- 10.5 Diagnostic centers - Market size and forecast 2025-2030
- 10.6 Research laboratories - Market size and forecast 2025-2030
- 10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Australia - Market size and forecast 2025-2030
- 12.6.2 Brazil - Market size and forecast 2025-2030
- 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 UAE - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Chile - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising global prevalence of autoimmune disorders
- Technological advancements in multiplex assays and laboratory automation
- Heightened patient awareness and favorable healthcare initiatives
- 13.2 Market challenges
- High financial burden and limited reimbursement frameworks
- Complex pathological overlaps and diagnostic ambiguity
- Vulnerabilities in specialty reagent supply chains and strict regulatory scrutiny
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Adoption of multiplex autoantibody assays and high-throughput automation
- Integration of AI and advanced data analytics
- Expansion of POC testing and decentralized diagnostics
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Autoimmune Technologies LLC
- Autoimmune Technologies LLC - Overview
- Autoimmune Technologies LLC - Product / Service
- Autoimmune Technologies LLC - Key offerings
- SWOT
- 15.5 Beckman Coulter Inc.
- Beckman Coulter Inc. - Overview
- Beckman Coulter Inc. - Product / Service
- Beckman Coulter Inc. - Key offerings
- SWOT
- 15.6 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.7 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
- 15.8 DiaSorin SpA
- DiaSorin SpA - Overview
- DiaSorin SpA - Business segments
- DiaSorin SpA - Key news
- DiaSorin SpA - Key offerings
- DiaSorin SpA - Segment focus
- SWOT
- 15.9 Exagen Inc.
- Exagen Inc. - Overview
- Exagen Inc. - Product / Service
- Exagen Inc. - Key offerings
- SWOT
- 15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.11 Gold Standard Diagnostics Corp.
- Gold Standard Diagnostics Corp. - Overview
- Gold Standard Diagnostics Corp. - Product / Service
- Gold Standard Diagnostics Corp. - Key offerings
- SWOT
- 15.12 Grifols SA
- Grifols SA - Overview
- Grifols SA - Business segments
- Grifols SA - Key offerings
- Grifols SA - Segment focus
- SWOT
- 15.13 Hemagen Diagnostics Inc.
- Hemagen Diagnostics Inc. - Overview
- Hemagen Diagnostics Inc. - Product / Service
- Hemagen Diagnostics Inc. - Key offerings
- SWOT
- 15.14 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
- 15.15 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- SWOT
- 15.16 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 15.17 Siemens AG
- Siemens AG - Overview
- Siemens AG - Business segments
- Siemens AG - Key news
- Siemens AG - Key offerings
- Siemens AG - Segment focus
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
